About Research Events Centers Newsroom Currency of Ideas
 
Milken Institute | Research | Publications | Financial Innovations Lab Reports: Innovative Financing for Global Health R&D
 Innovative Financing for Global Health R&D
Innovative Financing for Global Health R&D

New, effective investment models work to fund drug discovery for the developing world
Milken Institute report identifies innovative financing for global health research

The world of medicine has long been divided between developed countries that can afford cutting-edge treatments and developing ones whose poor populations too often go without urgently needed care. Because the eradication of diseases like TB and malaria would make a dramatic impact on emerging economies, investors in these countries including multinational aid providers, foundations, corporations and institutional funds must work together in innovative ways to increase the pool of capital available to drive drug discovery.

A new report from the Milken Institute,Innovative Financing for Global Health R&D,explores ways to broaden the flow of capital to bridge the divide and get more treatments for diseases that primarily affect the developing world.

To explore the most effective financial models to fund the development of drug treatments and vaccines, the Milken Institute convened a Financial Innovations Lab® with support from the Bill & Melinda Gates Foundation. Lab participants, who included global health advocates and public- and private-sector investors, concluded that research and development for developing-world diseases can now represent opportunities to engage investors, apart from the traditional donors, with demonstrable financial and social returns.

The Institute's report outlines strategies for improving and expanding the use of financial tools to engage the largest pools of capital available, including:

• Developing more efficient ways for donors to be involved
• Implementing blended-capital mechanisms that spread risk among funders with different needs
• Implementing capital market-based models that can bring new investors to R&D
• Exploring new private-sector models that rely on mechanisms such as exchange-traded funds and GDP-linked securities
• Creating innovative partnerships that pair funding organizations with entities that have local-market expertise and infrastructure.

 
Search All Publications
2 ways to subscribe to
the Milken Institute Review
Download the app for
iPhone, iPad and Kindle

Buy new digital editions of our quarterly economics journal for $1.99, purchase back issues for 99 cents or get a year's subscription for $5.99. Access links to related video and other content.
Order a 1-year subscription
Receive hard copies for $59, a small price to pay for our edgy, accessible and expert take on the latest in economics.
About Us
  Careers
  Contact
  Download Annual Report
  FAQs
  Locations
  Our Team

Blog


Topics

Events
  Associates
  Conferences
  Global Conference
  State of the State
  Summits
  Atlanta / California / London
  Forums
  Labs
  Young Leaders

Experts
Newsroom
  Latest News
  News Videos
  Press Releases

Research
  Centers
    Asia
    California
    FasterCures
    Financial Markets
    Israel Center
    Public Health

Initiatives

Publications
  Books
  Financial Innovations Labs
  Milken Institute Review
   Amazon Apps
   App Store
  Research Reports
  Viewpoints
  Search All Publications
Support MI
  Associates
  Donate
  Sponsorships
  Strategic Partners

Follow Us
  @Twitter
  Facebook
  YouTube
  Google+
  LinkedIn
  iTunes U

Related Sites
  Partnering For Cures 2013
  Celebration of Science
  Chairman's Corner
  Melanoma Research Alliance
  FasterCures

©2014 Milken Institute